Sodium heparin
This medicine should always be used exactly as described in the package leaflet or as directed by a doctor, pharmacist, or nurse.
Heparin-Hasco is intended for topical use on the skin. Topically applied heparin has anticoagulant, anti-inflammatory, and anti-edema effects.
Heparin-Hasco is indicated as an adjunctive treatment for:
Before starting to use Heparin-Hasco, the patient should discuss it with their doctor, pharmacist, or nurse.
Particular caution should be exercised when using Heparin-Hasco in patients with known bleeding disorders.
Prolonged use of the medicine may cause skin hypersensitivity reactions in some patients.
If skin changes (redness, rash, itching, burning, erythema) occur, the medicine should be discontinued.
The appearance of the skin should be monitored during the use of the medicine.
The medicine should not be used in children due to the lack of clinical studies on its efficacy and safety in this patient group.
The patient should inform their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to use.
Topically applied heparin in the form of a gel is only slightly absorbed into the bloodstream. Due to the low concentration of heparin in plasma, interactions with other medicines are negligible. Only in patients with bleeding disorders, prolonged use of the medicine on large skin areas simultaneously with anticoagulant medicines may enhance the anticoagulant effect. It is recommended to monitor blood coagulation parameters.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medicine.
Pregnancy
Heparin does not cross the placenta; however, during pregnancy, the medicine should be used with caution and only when necessary.
Breastfeeding
Heparin does not pass into breast milk; however, during breastfeeding, the medicine should be used with caution and only when necessary.
Fertility
No data available.
There are no data available on the effect of the medicine on the ability to drive and use machines.
The medicine may cause skin irritation.
The medicine may cause allergic reactions (possible late reactions).
This medicine should always be used exactly as described in the package leaflet or as directed by a doctor, pharmacist, or nurse. In case of doubts, the patient should consult their doctor, pharmacist, or nurse.
The medicine is intended for topical use on the skin.
A thin layer of the gel (a strip of 3 cm to 10 cm) should be evenly applied to the affected area, 2 to 3 times a day.
After using the medicine, the patient should wash their hands thoroughly.
Like all medicines, Heparin-Hasco can cause side effects, although not everybody gets them.
During prolonged use of the medicine, skin allergic reactions may occur: redness, itching, rash, burning, erythema, skin inflammation.
Some people may experience other side effects while using Heparin-Hasco.
If the patient experiences any side effects, including any possible side effects not listed in the leaflet, they should inform their doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Post-Marketing Surveillance of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Aleje Jerozolimskie 181C, 02-222 Warsaw
tel.: +48 22 49 21 301, fax: +48 22 49 21 309
e-mail: ndl@urpl.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medicine.
Store in a temperature below 25°C.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines they no longer use. This will help protect the environment.
Heparin-Hasco is a colorless gel with a rose fragrance.
One package of the medicine contains 35 g of the gel.
“PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK” S.A.
51-131 Wrocław, ul. Żmigrodzka 242 E
Medicine Information
tel. +48 (22) 742 00 22
e-mail: informacjaoleku@hasco-lek.pl
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.